Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
X Financial A ADR | XYF | 25. avr 2024 | 3.79 | -1.04 |
X3 Holdings | XTKG | 25. avr 2024 | 0.62 | 0.00 |
X4 Pharmaceuticals | XFOR | 25. avr 2024 | 1.13 | -12.40 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | 25. avr 2024 | 7.01 | +0.43 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | 25. avr 2024 | 24.45 | +0.16 |
XBiotech | XBIT | 25. avr 2024 | 8.21 | +1.73 |
XBP Europe | XBP | 25. avr 2024 | 1.26 | +1.61 |
Xcel Brands | XELB | 25. avr 2024 | 0.71 | 0.00 |
Xcel Energy | XEL | 25. avr 2024 | 55.01 | -0.58 |
Xencor | XNCR | 25. avr 2024 | 19.23 | +1.10 |
Xenetic Biosciences | XBIO | 25. avr 2024 | 3.78 | -1.92 |
Xenia Hotels & Resorts | XHR | 25. avr 2024 | 14.14 | -2.68 |
Xenon Pharmaceuticals | XENE | 25. avr 2024 | 40.10 | +1.52 |
Xeris Biopharma | XERS | 25. avr 2024 | 1.70 | -3.41 |
Xerox | XRX | 25. avr 2024 | 14.18 | -1.39 |
XIAO-I ADR | AIXI | 25. avr 2024 | 1.28 | +4.07 |
Xilio Therapeutics | XLO | 25. avr 2024 | 1.01 | -4.72 |
Xinyuan Real Estate ADR | XIN | 25. avr 2024 | 2.72 | -0.37 |
XOMA | XOMA | 25. avr 2024 | 25.36 | -1.09 |
XOMA A Pref | XOMAP | 25. avr 2024 | 24.99 | +0.56 |
XOMA B Pref | XOMAO | 25. avr 2024 | 25.00 | 0.00 |
Xometry A | XMTR | 25. avr 2024 | 16.92 | +0.18 |
XORTX Therapeutics | XRTX | 25. avr 2024 | 2.59 | -10.75 |
Xos | XOS | 25. avr 2024 | 7.59 | -0.52 |
XP A | XP | 25. avr 2024 | 20.55 | -0.44 |
XPEL | XPEL | 25. avr 2024 | 53.77 | -3.90 |
XPeng A ADR | XPEV | 25. avr 2024 | 7.08 | 0.00 |
Xperi | XPER | 25. avr 2024 | 9.83 | -1.50 |
XPO Logistics | XPO | 25. avr 2024 | 118.25 | +0.66 |
Xponential Fitness A | XPOF | 25. avr 2024 | 12.47 | -0.64 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.